A. C. Matin

Last updated
  1. 1 2 3 "AC Matin".
  2. Tabor, Abigail (November 16, 2017). "NASA Is Sending E. coli to Space for Astronaut Health". NASA.
  3. "AC Matin". Stanford Woods Institute for the Environment. June 21, 2018.
  4. "A. C. Matin - Professor of Microbiology and Immunology". Welcome to Bio-X. March 7, 2014.
  5. "Ion Transport in Acidophiles" (PDF).
  6. Thorne, S. H.; Barak, Y.; Liang, W.; Bachmann, M. H.; Rao, J.; Contag, C. H.; Matin, A. (2009). "Europe PMC". Molecular Cancer Therapeutics. 8 (2): 333–341. doi:10.1158/1535-7163.MCT-08-0707. PMC   2670992 . PMID   19190118.
  7. Barak Y, Thorne SH, Ackerley DF, Lynch SV, Contag CH, Matin A (January 2006). "New enzyme for reductive cancer chemotherapy, YieF, and its improvement by directed evolution". Molecular Cancer Therapeutics. 5 (1): 97–103. doi: 10.1158/1535-7163.MCT-05-0365 . PMID   16432167.
  8. Barak Y, Ackerley DF, Dodge CJ, Banwari L, Alex C, Francis AJ, Matin A (November 2006). "Analysis of novel soluble chromate and uranyl reductases and generation of an improved enzyme by directed evolution". Applied and Environmental Microbiology. 72 (11): 7074–82. Bibcode:2006ApEnM..72.7074B. doi:10.1128/AEM.01334-06. PMC   1636143 . PMID   17088379.
  9. Barak Y, Nov Y, Ackerley DF, Matin A (February 2008). "Enzyme improvement in the absence of structural knowledge: a novel statistical approach". The ISME Journal. 2 (2): 171–9. Bibcode:2008ISMEJ...2..171B. doi: 10.1038/ismej.2007.100 . PMID   18253133.
  10. Eswaramoorthy S, Poulain S, Hienerwadel R, Bremond N, Sylvester MD, Zhang YB, et al. (April 27, 2012). "Crystal structure of ChrR--a quinone reductase with the capacity to reduce chromate". PLOS ONE. 7 (4): e36017. Bibcode:2012PLoSO...736017E. doi: 10.1371/journal.pone.0036017 . PMC   3338774 . PMID   22558308.
  11. Wang JH, Endsley AN, Green CE, Matin AC (July 2016). "Utilizing native fluorescence imaging, modeling and simulation to examine pharmacokinetics and therapeutic regimen of a novel anticancer prodrug". BMC Cancer. 16 (1): 524. doi: 10.1186/s12885-016-2508-6 . PMC   4960810 . PMID   27457630.
  12. 1 2 Forterre AV, Wang JH, Delcayre A, Kim K, Green C, Pegram MD, et al. (March 2020). "Extracellular Vesicle-Mediated In Vitro Transcribed mRNA Delivery for Treatment of HER2+ Breast Cancer Xenografts in Mice by Prodrug CB1954 without General Toxicity". Molecular Cancer Therapeutics. 19 (3): 858–867. doi: 10.1158/1535-7163.MCT-19-0928 . PMC   7056535 . PMID   31941722.
  13. 1 2 Wang JH, Forterre AV, Zhao J, Frimannsson DO, Delcayre A, Antes TJ, et al. (May 2018). "Anti-HER2 scFv-Directed Extracellular Vesicle-Mediated mRNA-Based Gene Delivery Inhibits Growth of HER2-Positive Human Breast Tumor Xenografts by Prodrug Activation". Molecular Cancer Therapeutics. 17 (5): 1133–1142. doi: 10.1158/1535-7163.MCT-17-0827 . PMC   5932266 . PMID   29483213.
  14. Jay, Steven M. (March 21, 2018). "An EVolving approach to directed enzyme prodrug therapy for cancer". Science Translational Medicine . 10 (433): eaat1642. doi:10.1126/scitranslmed.aat1642. S2CID   13682809.
  15. Benoit MR, Mayer D, Barak Y, Chen IY, Hu W, Cheng Z, et al. (August 2009). "Visualizing implanted tumors in mice with magnetic resonance imaging using magnetotactic bacteria". Clinical Cancer Research. 15 (16): 5170–7. doi: 10.1158/1078-0432.CCR-08-3206 . PMC   3409839 . PMID   19671860.
  16. Matin A, Veldkamp H (April 1978). "Physiological basis of the selective advantage of a Spirillum sp. in a carbon-limited environment". Journal of General Microbiology. 105 (2): 187–97. doi: 10.1099/00221287-105-2-187 . PMID   641523.
  17. Matin, A.; Grootjans, A.; Hogenhuis, H. (1976). "Influence of dilution rate on enzymes of intermediary metabolism in two freshwater bacteria grown in continuous culture" (PDF). Journal of General Microbiology. 94 (2): 323–332. doi:10.1099/00221287-94-2-323. PMID   950555. S2CID   29754140.
  18. 1 2 Wang, Jing-Hung; Singh, Rachna; Benoit, Michael; Keyhan, Mimi; Sylvester, Matthew; Hsieh, Michael; Thathireddy, Anuradha; Hsieh, Yi-Ju; Matin, A. C. (October 1, 2014). "Sigma S-Dependent Antioxidant Defense Protects Stationary-Phase Escherichia coli against the Bactericidal Antibiotic Gentamicin". Antimicrobial Agents and Chemotherapy. 58 (10): 5964–5975. doi: 10.1128/AAC.03683-14 . PMC   4187989 . PMID   25070093.
  19. Groat, R. G.; Schultz, J. E.; Zychlinsky, E.; Bockman, A.; Matin, A. (November 1, 1986). "Starvation proteins in Escherichia coli: kinetics of synthesis and role in starvation survival". Journal of Bacteriology. 168 (2): 486–493. doi: 10.1128/jb.168.2.486-493.1986 . PMC   213508 . PMID   3536847.
  20. 1 2 Reeve, C. A.; Amy, P. S.; Matin, A. (December 1, 1984). "Role of protein synthesis in the survival of carbon-starved Escherichia coli K-12". Journal of Bacteriology. 160 (3): 1041–1046. doi:10.1128/JB.160.3.1041-1046.1984. PMC   215816 . PMID   6389505.
  21. 1 2 Schultz, J. E.; Latter, G. I.; Matin, A. (September 1, 1988). "Differential regulation by cyclic AMP of starvation protein synthesis in Escherichia coli". Journal of Bacteriology. 170 (9): 3903–3909. doi: 10.1128/jb.170.9.3903-3909.1988 . PMC   211388 . PMID   2842291.
  22. Jenkins, D. E.; Schultz, J. E.; Matin, A. (1988). "Starvation-induced cross protection against heat or H2O2 challenge in Escherichia coli". Journal of Bacteriology. 170 (9): 3910–3914. doi:10.1128/jb.170.9.3910-3914.1988. PMC   211389 . PMID   3045081.
  23. Jenkins, D. E.; Chaisson, S. A.; Matin, A. (1990). "Starvation-induced cross protection against osmotic challenge in Escherichia coli". Journal of Bacteriology. 172 (5): 2779–2781. doi:10.1128/jb.172.5.2779-2781.1990. PMC   208926 . PMID   2185233.
  24. McCann, M. P.; Kidwell, J. P.; Matin, A. (1991). "The putative sigma factor KatF has a central role in development of starvation-mediated general resistance in Escherichia coli". Journal of Bacteriology. 173 (13): 4188–4194. doi:10.1128/jb.173.13.4188-4194.1991. PMC   208069 . PMID   2061293.
  25. "Stress, Bacterial:General and Specific. Reference Module in Biomedical Science" (PDF).
  26. Sonenshein AL (April 2005). "CodY, a global regulator of stationary phase and virulence in Gram-positive bacteria". Current Opinion in Microbiology. 8 (2): 203–7. doi:10.1016/j.mib.2005.01.001. PMID   15802253.
  27. 1 2 Schweder, T.; Lee, K. H.; Lomovskaya, O.; Matin, A. (January 1, 1996). "Regulation of Escherichia coli starvation sigma factor (sigma s) by ClpXP protease". Journal of Bacteriology. 178 (2): 470–476. doi: 10.1128/jb.178.2.470-476.1996 . PMC   177680 . PMID   8550468.
  28. Matin, A. (1991). "The molecular basis of carbon-starvation-induced general resistance in Escherichia coli". Molecular Microbiology. 5 (1): 3–10. doi:10.1111/j.1365-2958.1991.tb01819.x. PMID   2014002. S2CID   12518946.
  29. Lynch, S. V.; Brodie, E. L.; Matin, A. (December 16, 2004). "Role and Regulation of σs in General Resistance Conferred by Low-Shear Simulated Microgravity in Escherichia coli". Journal of Bacteriology. 186 (24): 8207–8212. doi: 10.1128/JB.186.24.8207-8212.2004 . PMC   532419 . PMID   15576768.
  30. Singh, Rachna; Matin, A. C. (April 16, 2016). Nickerson, Cheryl A.; Pellis, Neal R.; Ott, C. Mark (eds.). Effect of Spaceflight and Spaceflight Analogue Culture on Human and Microbial Cells: Novel Insights into Disease Mechanisms. Springer. pp. 259–282. doi:10.1007/978-1-4939-3277-1_13.
  31. Blum, Paul; Velligan, Mark; Lin, Norman; Matin, Abdul (1992). "DnaK-Mediated Alterations in Human Growth Hormone Protein Inclusion Bodies". Nature Biotechnology. 10 (3): 301–304. doi:10.1038/nbt0392-301. PMID   1369475. S2CID   2467334.
  32. Xiong, A.; Gottman, A.; Park, C.; Baetens, M.; Pandza, S.; Matin, A. (October 1, 2000). "The EmrR Protein Represses the Escherichia coli emrRAB Multidrug Resistance Operon by Directly Binding to Its Promoter Region". Antimicrobial Agents and Chemotherapy. 44 (10): 2905–2907. doi: 10.1128/AAC.44.10.2905-2907.2000 . PMC   90178 . PMID   10991887.
  33. 1 2 Lomovskaya, O.; Lewis, K.; Matin, A. (May 1, 1995). "EmrR is a negative regulator of the Escherichia coli multidrug resistance pump EmrAB". Journal of Bacteriology. 177 (9): 2328–2334. doi: 10.1128/jb.177.9.2328-2334.1995 . PMC   176888 . PMID   7730261.
  34. Lomovskaya, O.; Kawai, F.; Matin, A. (1996). "Differential regulation of the mcb and emr operons of Escherichia coli: role of mcb in multidrug resistance". Antimicrobial Agents and Chemotherapy. 40 (4): 1050–1052. doi:10.1128/AAC.40.4.1050. PMC   163261 . PMID   8849229.
  35. Lynch, S. V.; Mukundakrishnan, K.; Benoit, M. R.; Ayyaswamy, P. S.; Matin, A. (December 1, 2006). "Escherichia coli Biofilms Formed under Low-Shear Modeled Microgravity in a Ground-Based System". Applied and Environmental Microbiology. 72 (12): 7701–7710. Bibcode:2006ApEnM..72.7701L. doi: 10.1128/AEM.01294-06 . PMC   1694224 . PMID   17028231.
  36. Matin, A.C.; Wang, J.-H.; Keyhan, Mimi; Singh, Rachna; Benoit, Michael; Parra, Macarena P.; Padgen, Michael R.; Ricco, Antonio J.; Chin, Matthew; Friedericks, Charlie R.; Chinn, Tori N.; Cohen, Aaron; Henschke, Michael B.; Snyder, Timothy V.; Lera, Matthew P.; Ross, Shannon S.; Mayberry, Christina M.; Choi, Sungshin; Wu, Diana T.; Tan, Ming X.; Boone, Travis D.; Beasley, Christopher C.; Piccini, Matthew E.; Spremo, Stevan M. (November 1, 2017). "Payload hardware and experimental protocol development to enable future testing of the effect of space microgravity on the resistance to gentamicin of uropathogenic Escherichia coli and its σs-deficient mutant". Life Sciences in Space Research. 15: 1–10. Bibcode:2017LSSR...15....1M. doi:10.1016/j.lssr.2017.05.001. PMID   29198308.
  37. Padgen, Michael R.; Lera, Matthew P.; Parra, Macarena P.; Ricco, Antonio J.; Chin, Matthew; Chinn, Tori N.; Cohen, Aaron; Friedericks, Charlie R.; Henschke, Michael B.; Snyder, Timothy V.; Spremo, Stevan M.; Wang, Jing-Hung; Matin, A.C. (February 1, 2020). "EcAMSat spaceflight measurements of the role of σs in antibiotic resistance of stationary phase Escherichia coli in microgravity". Life Sciences in Space Research. 24: 18–24. Bibcode:2020LSSR...24...18P. doi: 10.1016/j.lssr.2019.10.007 . PMID   31987476.
  38. "Payload hardware and experimental protocol development to enable future testing of the effect of space microgravity on the resistance to gentamicin of uropathogenic Escherichia coli and its σs-deficient mutant" (PDF).
  39. Stone, G.; Wood, P.; Dixon, L.; Keyhan, M.; Matin, A. (August 16, 2002). "Tetracycline Rapidly Reaches All the Constituent Cells of Uropathogenic Escherichia coli Biofilms". Antimicrobial Agents and Chemotherapy. 46 (8): 2458–2461. doi: 10.1128/AAC.46.8.2458-2461.2002 . PMC   127323 . PMID   12121918.
  40. Lynch, S. V.; Dixon, L.; Benoit, M. R.; Brodie, E. L.; Keyhan, M.; Hu, P.; Ackerley, D. F.; Andersen, G. L.; Matin, A. (October 1, 2007). "Role of the rapA Gene in Controlling Antibiotic Resistance of Escherichia coli Biofilms". Antimicrobial Agents and Chemotherapy. 51 (10): 3650–3658. doi: 10.1128/AAC.00601-07 . PMC   2043260 . PMID   17664315.
  41. "Targets of Improvement in Bacterial Chromate Bioremediation" (PDF).
  42. Ackerley, D. F.; Gonzalez, C. F.; Keyhan, M.; Blake, R.; Matin, A. (2004). "Mechanism of chromate reduction by the Escherichia coli protein, NfsA, and the role of different chromate reductases in minimizing oxidative stress during chromate reduction". Environmental Microbiology. 6 (8): 851–860. Bibcode:2004EnvMi...6..851A. doi:10.1111/j.1462-2920.2004.00639.x. PMID   15250887.
  43. Ackerley, D. F.; Barak, Y.; Lynch, S. V.; Curtin, J.; Matin, A. (May 16, 2006). "Effect of chromate stress on Escherichia coli K-12". Journal of Bacteriology. 188 (9): 3371–3381. doi:10.1128/JB.188.9.3371-3381.2006. PMC   1447458 . PMID   16621832.
  44. Gonzalez, Claudio F.; Ackerley, David F.; Lynch, Susan V.; Matin, A. (June 17, 2005). "ChrR, a Soluble Quinone Reductase of Pseudomonas putida That Defends against H2O2*". Journal of Biological Chemistry. 280 (24): 22590–22595. doi: 10.1074/jbc.M501654200 . PMID   15840577.
  45. "Editorial Board". London Journals Press.

Related Research Articles

<i>Escherichia coli</i> Enteric, rod-shaped, gram-negative bacterium

Escherichia coli ( ESH-ə-RIK-ee-ə KOH-ly) is a gram-negative, facultative anaerobic, rod-shaped, coliform bacterium of the genus Escherichia that is commonly found in the lower intestine of warm-blooded organisms. Most E. coli strains are harmless, but some serotypes such as EPEC, and ETEC are pathogenic and can cause serious food poisoning in their hosts, and are occasionally responsible for food contamination incidents that prompt product recalls. Most strains are part of the normal microbiota of the gut and are harmless or even beneficial to humans (although these strains tend to be less studied than the pathogenic ones). For example, some strains of E. coli benefit their hosts by producing vitamin K2 or by preventing the colonization of the intestine by pathogenic bacteria. These mutually beneficial relationships between E. coli and humans are a type of mutualistic biological relationship — where both the humans and the E. coli are benefitting each other. E. coli is expelled into the environment within fecal matter. The bacterium grows massively in fresh fecal matter under aerobic conditions for three days, but its numbers decline slowly afterwards.

<span class="mw-page-title-main">Biofilm</span> Aggregation of bacteria or cells on a surface

A biofilm is a syntrophic community of microorganisms in which cells stick to each other and often also to a surface. These adherent cells become embedded within a slimy extracellular matrix that is composed of extracellular polymeric substances (EPSs). The cells within the biofilm produce the EPS components, which are typically a polymeric combination of extracellular polysaccharides, proteins, lipids and DNA. Because they have a three-dimensional structure and represent a community lifestyle for microorganisms, they have been metaphorically described as "cities for microbes".

<span class="mw-page-title-main">Filamentation</span> Type of bacteria growth

Filamentation is the anomalous growth of certain bacteria, such as Escherichia coli, in which cells continue to elongate but do not divide. The cells that result from elongation without division have multiple chromosomal copies.

<span class="mw-page-title-main">Efflux pump</span> Protein complexes that move compounds, generally toxic, out of bacterial cells

An efflux pump is an active transporter in cells that moves out unwanted material. Efflux pumps are an important component in bacteria in their ability to remove antibiotics. The efflux could also be the movement of heavy metals, organic pollutants, plant-produced compounds, quorum sensing signals, bacterial metabolites and neurotransmitters. All microorganisms, with a few exceptions, have highly conserved DNA sequences in their genome that encode efflux pumps. Efflux pumps actively move substances out of a microorganism, in a process known as active efflux, which is a vital part of xenobiotic metabolism. This active efflux mechanism is responsible for various types of resistance to bacterial pathogens within bacterial species - the most concerning being antibiotic resistance because microorganisms can have adapted efflux pumps to divert toxins out of the cytoplasm and into extracellular media.

The gene rpoS encodes the sigma factor sigma-38, a 37.8 kD protein in Escherichia coli. Sigma factors are proteins that regulate transcription in bacteria. Sigma factors can be activated in response to different environmental conditions. rpoS is transcribed in late exponential phase, and RpoS is the primary regulator of stationary phase genes. RpoS is a central regulator of the general stress response and operates in both a retroactive and a proactive manner: it not only allows the cell to survive environmental challenges, but it also prepares the cell for subsequent stresses (cross-protection). The transcriptional regulator CsgD is central to biofilm formation, controlling the expression of the curli structural and export proteins, and the diguanylate cyclase, adrA, which indirectly activates cellulose production. The rpoS gene most likely originated in the gammaproteobacteria.

fis E. coli gene

fis is an E. coli gene encoding the Fis protein. The regulation of this gene is more complex than most other genes in the E. coli genome, as Fis is an important protein which regulates expression of other genes. It is supposed that fis is regulated by H-NS, IHF and CRP. It also regulates its own expression (autoregulation). Fis is one of the most abundant DNA binding proteins in Escherichia coli under nutrient-rich growth conditions.

<span class="mw-page-title-main">RyhB</span> 90 nucleotide RNA

RyhB RNA is a 90 nucleotide RNA that down-regulates a set of iron-storage and iron-using proteins when iron is limiting; it is itself negatively regulated by the ferric uptake repressor protein, Fur.

Persister cells are subpopulations of cells that resist treatment, and become antimicrobial tolerant by changing to a state of dormancy or quiescence. Persister cells in their dormancy do not divide. The tolerance shown in persister cells differs from antimicrobial resistance in that the tolerance is not inherited and is reversible. When treatment has stopped the state of dormancy can be reversed and the cells can reactivate and multiply. Most persister cells are bacterial, and there are also fungal persister cells, yeast persister cells, and cancer persister cells that show tolerance for cancer drugs.

<span class="mw-page-title-main">SpoT</span>

Bifunctional (p)ppGpp synthase/hydrolase SpoT or SpoT is a regulatory enzyme in the RelA/SpoT Homologue (RSH) protein family that synthesizes and hydrolyzes (p)ppGpp to regulate the bacterial stringent response to environmental stressors. SpoT is considered a "long" form RSH protein and is found in many bacteria and plant chloroplasts. SpoT and its homologues have been studied in bacterial model organism E.coli for their role in the production and degradation of (p)ppGpp in the stringent response pathway.

Roberto Kolter is Professor of Microbiology, Emeritus at Harvard Medical School, an author, and past president of the American Society for Microbiology. Kolter has been a professor at Harvard Medical School since 1983 and was Co-director of Harvard's Microbial Sciences Initiative from 2003-2018. During the 35-year term of the Kolter laboratory from 1983 to 2018, more than 130 graduate student and postdoctoral trainees explored an eclectic mix of topics gravitating around the study of microbes. Kolter is a fellow of the American Association for the Advancement of Science and of the American Academy of Microbiology.

Bacterial small RNAs are small RNAs produced by bacteria; they are 50- to 500-nucleotide non-coding RNA molecules, highly structured and containing several stem-loops. Numerous sRNAs have been identified using both computational analysis and laboratory-based techniques such as Northern blotting, microarrays and RNA-Seq in a number of bacterial species including Escherichia coli, the model pathogen Salmonella, the nitrogen-fixing alphaproteobacterium Sinorhizobium meliloti, marine cyanobacteria, Francisella tularensis, Streptococcus pyogenes, the pathogen Staphylococcus aureus, and the plant pathogen Xanthomonas oryzae pathovar oryzae. Bacterial sRNAs affect how genes are expressed within bacterial cells via interaction with mRNA or protein, and thus can affect a variety of bacterial functions like metabolism, virulence, environmental stress response, and structure.

<span class="mw-page-title-main">Toxin-antitoxin system</span> Biological process

A toxin-antitoxin system consists of a "toxin" and a corresponding "antitoxin", usually encoded by closely linked genes. The toxin is usually a protein while the antitoxin can be a protein or an RNA. Toxin-antitoxin systems are widely distributed in prokaryotes, and organisms often have them in multiple copies. When these systems are contained on plasmids – transferable genetic elements – they ensure that only the daughter cells that inherit the plasmid survive after cell division. If the plasmid is absent in a daughter cell, the unstable antitoxin is degraded and the stable toxic protein kills the new cell; this is known as 'post-segregational killing' (PSK).

<span class="mw-page-title-main">Plasmid-mediated resistance</span> Antibiotic resistance caused by a plasmid

Plasmid-mediated resistance is the transfer of antibiotic resistance genes which are carried on plasmids. Plasmids possess mechanisms that ensure their independent replication as well as those that regulate their replication number and guarantee stable inheritance during cell division. By the conjugation process, they can stimulate lateral transfer between bacteria from various genera and kingdoms. Numerous plasmids contain addiction-inducing systems that are typically based on toxin-antitoxin factors and capable of killing daughter cells that don't inherit the plasmid during cell division. Plasmids often carry multiple antibiotic resistance genes, contributing to the spread of multidrug-resistance (MDR). Antibiotic resistance mediated by MDR plasmids severely limits the treatment options for the infections caused by Gram-negative bacteria, especially family Enterobacteriaceae. The global spread of MDR plasmids has been enhanced by selective pressure from antimicrobial medications used in medical facilities and when raising animals for food.

Thymineless death is the phenomenon by which bacteria, yeasts and mammalian cells undergo cell death when they are starved of thymidine triphosphate (dTTP), an essential precursor for DNA replication. This phenomenon underlies the mechanism of action of several antibacterial, antimalarial and anticancer agents, such as trimethoprim, sulfamethoxazole, methotrexate and fluorouracil.

Pathogenic <i>Escherichia coli</i> Strains of E. coli that can cause disease

Escherichia coli is a gram-negative, rod-shaped bacterium that is commonly found in the lower intestine of warm-blooded organisms (endotherms). Most E. coli strains are harmless, but pathogenic varieties cause serious food poisoning, septic shock, meningitis, or urinary tract infections in humans. Unlike normal flora E. coli, the pathogenic varieties produce toxins and other virulence factors that enable them to reside in parts of the body normally not inhabited by E. coli, and to damage host cells. These pathogenic traits are encoded by virulence genes carried only by the pathogens.

<span class="mw-page-title-main">Universal stress protein</span>

The universal stress protein (USP) domain is a superfamily of conserved genes which can be found in bacteria, archaea, fungi, protozoa and plants. Proteins containing the domain are induced by many environmental stressors such as nutrient starvation, drought, extreme temperatures, high salinity, and the presence of uncouplers, antibiotics and metals.

<span class="mw-page-title-main">Curli</span> A proteinaceous extracellular fiber produced by enteric bacteria

The Curli protein is a type of amyloid fiber produced by certain strains of enterobacteria. They are extracellular fibers located on bacteria such as E. coli and Salmonella spp. These fibers serve to promote cell community behavior through biofilm formation in the extracellular matrix. Amyloids are associated with several human neurodegenerative diseases such as Alzheimer's disease, Huntington's disease, Parkinson's disease, and prion diseases. The study of curli may help to understand human diseases thought to arise from improper amyloid fiber formation. The curli pili are generally assembled through the extracellular nucleation precipitation pathway.

<span class="mw-page-title-main">Bacterial secretion system</span> Protein complexes present on the cell membranes of bacteria for secretion of substances

Bacterial secretion systems are protein complexes present on the cell membranes of bacteria for secretion of substances. Specifically, they are the cellular devices used by pathogenic bacteria to secrete their virulence factors to invade the host cells. They can be classified into different types based on their specific structure, composition and activity. Generally, proteins can be secreted through two different processes. One process is a one-step mechanism in which proteins from the cytoplasm of bacteria are transported and delivered directly through the cell membrane into the host cell. Another involves a two-step activity in which the proteins are first transported out of the inner cell membrane, then deposited in the periplasm, and finally through the outer cell membrane into the host cell.

<span class="mw-page-title-main">Pho regulon</span> Phosphate regulatory mechanism in cells

The Phosphate (Pho) regulon is a regulatory mechanism used for the conservation and management of inorganic phosphate within the cell. It was first discovered in Escherichia coli as an operating system for the bacterial strain, and was later identified in other species. The Pho system is composed of various components including extracellular enzymes and transporters that are capable of phosphate assimilation in addition to extracting inorganic phosphate from organic sources. This is an essential process since phosphate plays an important role in cellular membranes, genetic expression, and metabolism within the cell. Under low nutrient availability, the Pho regulon helps the cell survive and thrive despite a depletion of phosphate within the environment. When this occurs, phosphate starvation-inducible (psi) genes activate other proteins that aid in the transport of inorganic phosphate.

Colanic acid is an exopolysaccharide synthesized by bacteria in the Enterobacteriaceae family. It is excreted by the cell to form a protective bacterial capsule, and it assists in the formation of biofilms.

A. C. Matin
Born1941
Delhi, India
DiedApril 14, 2024
Stanford, CA
Nationality (legal) Pakistani-American
Occupation(s)Microbiologist, immunologist, and academician
AwardsElected fellow, American Academy of Microbiology
Elected Associate Fellow, Aerospace Medical Association
Recipient of NASA honor award for the ECAMSAT Project
Review Committee of the Accreditation Board for Engineering and Technology (ABET)
Academic background
EducationB.S., microbiology
M.S., microbiology
Ph.D., microbiology
Alma mater University of Karachi, Pakistan
University of California, Los Angeles